Pages that link to "Q34215236"
Jump to navigation
Jump to search
The following pages link to The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). (Q34215236):
Displaying 50 items.
- THC Prevents MDMA Neurotoxicity in Mice (Q21090029) (← links)
- Use of ecstasy and other psychoactive substances among school-attending adolescents in Taiwan: national surveys 2004-2006 (Q21257199) (← links)
- The Potential Dangers of Using MDMA for Psychotherapy (Q21558619) (← links)
- The neurotoxicity of amphetamines during the adolescent period (Q21558652) (← links)
- Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA) (Q22251113) (← links)
- Toxicity of amphetamines: an update (Q22252794) (← links)
- Pharmacological enhancement of exposure-based treatment in PTSD: a qualitative review (Q22305514) (← links)
- 3,4-methylenedioxymethamphetamine (MDMA): current perspectives (Q24602762) (← links)
- Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA) (Q24619949) (← links)
- Mephedrone, an abused psychoactive component of 'bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum (Q24621938) (← links)
- Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern? (Q24627529) (← links)
- Disposition of MDMA and metabolites in human sweat following controlled MDMA administration (Q24658430) (← links)
- Comparative potencies of 3,4-methylenedioxymethamphetamine (MDMA) analogues as inhibitors of [3H]noradrenaline and [3H]5-HT transport in mammalian cell lines (Q24670108) (← links)
- Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB (Q24678394) (← links)
- Interactions between 3,4-methylenedioxymethamphetamine and sigma1 receptors (Q24683869) (← links)
- Chronic exposure to MDMA (Ecstasy) elicits behavioral sensitization in rats but fails to induce cross-sensitization to other psychostimulants (Q25256989) (← links)
- Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans (Q26859367) (← links)
- Neurocircuitry of drug reward (Q26862749) (← links)
- Ecstasy (MDMA) and its effects on kidneys and their treatment: a review (Q28069288) (← links)
- Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices (Q28243881) (← links)
- 4-Methyl-amphetamine: a health threat for recreational amphetamine users (Q28293168) (← links)
- Effects of adenosine A2a receptor agonist and antagonist on cerebellar nuclear factor-kB expression preceded by MDMA toxicity (Q28387121) (← links)
- The influence of genetic and environmental factors among MDMA users in cognitive performance (Q28477994) (← links)
- Effects of 3,4-methylenedioxymethamphetamine administration on retinal physiology in the rat (Q28478597) (← links)
- Role of the dopaminergic system in the acquisition, expression and reinstatement of MDMA-induced conditioned place preference in adolescent mice (Q28482310) (← links)
- Effect of ambient temperature on the thermoregulatory and locomotor stimulant effects of 4-methylmethcathinone in Wistar and Sprague-Dawley rats (Q28483306) (← links)
- Mephedrone in adolescent rats: residual memory impairment and acute but not lasting 5-HT depletion (Q28483841) (← links)
- Illicit stimulant use in humans is associated with a long-term increase in tremor (Q28484412) (← links)
- Verbal memory deficits are correlated with prefrontal hypometabolism in (18)FDG PET of recreational MDMA users (Q28486090) (← links)
- Illicit stimulant use is associated with abnormal substantia nigra morphology in humans (Q28486143) (← links)
- Hand function is altered in individuals with a history of illicit stimulant use (Q28542886) (← links)
- Non-Serotonergic Neurotoxicity by MDMA (Ecstasy) in Neurons Derived from Mouse P19 Embryonal Carcinoma Cells (Q28553620) (← links)
- Serotonergic neurotransmission in emotional processing: New evidence from long-term recreational poly-drug ecstasy use (Q29473848) (← links)
- The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA). (Q30341737) (← links)
- Mechanisms and environmental factors that underlying the intensification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced serotonin syndrome in rats (Q30387357) (← links)
- The preclinical pharmacology of mephedrone; not just MDMA by another name. (Q30412911) (← links)
- Serotonin: a regulator of neuronal morphology and circuitry (Q30430944) (← links)
- Cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of bioenergetic stress in ecstasy users (Q30478967) (← links)
- Behavioral and growth effects induced by low dose methamphetamine administration during the neonatal period in rats. (Q30486638) (← links)
- Behavioral genetic contributions to the study of addiction-related amphetamine effects (Q30494693) (← links)
- Treatment with MDMA from P11-20 disrupts spatial learning and path integration learning in adolescent rats but only spatial learning in older rats. (Q30495103) (← links)
- Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study (Q31005994) (← links)
- Ecstasy: are animal data consistent between species and can they translate to humans? (Q31033315) (← links)
- Extensive neuroadaptive changes in cortical gene-transcript expressions of the glutamate system in response to repeated intermittent MDMA administration in adolescent rats (Q33328978) (← links)
- MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study. (Q33390410) (← links)
- Addictive illegal drugs: structural neuroimaging (Q33513798) (← links)
- Prior MDMA (Ecstasy) use is associated with increased basal ganglia-thalamocortical circuit activation during motor task performance in humans: an fMRI study (Q33586450) (← links)
- Critical role of peripheral vasoconstriction in fatal brain hyperthermia induced by MDMA (Ecstasy) under conditions that mimic human drug use (Q33707843) (← links)
- Glucose and corticosterone changes in developing and adult rats following exposure to ( /-)-3,4-methylendioxymethamphetamine or 5-methoxydiisopropyltryptamine (Q33729739) (← links)
- Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in mice (Q33804240) (← links)